Differences

This shows you the differences between two versions of the page.

Link to this comparison view

Both sides previous revisionPrevious revision
Next revision		Previous revision
debunking-puberty-blockers [2025/12/29 15:18] – [References] valahdebunking-puberty-blockers [2025/12/29 15:21] (current) – [References] valah
Line 335: Line 335:
 [(pb8> Carswell, J. M., Finlayson, C., Bartolucci, A. A., Chen, D., & Hanna, S. (2022). The evolution of adolescent gender-affirming care. Hormone Research in Paediatrics, 95(6), 649–661. https://pubmed.ncbi.nlm.nih.gov/36446328/ .)] [(pb8> Carswell, J. M., Finlayson, C., Bartolucci, A. A., Chen, D., & Hanna, S. (2022). The evolution of adolescent gender-affirming care. Hormone Research in Paediatrics, 95(6), 649–661. https://pubmed.ncbi.nlm.nih.gov/36446328/ .)]
  
-[(pb9> Safer, J. D., & Coleman, E. (2016). Hormone therapy in transgender adults is safe with provider supervision. Journal of Clinical Endocrinology & Metabolism, 101(12), 4422–4426. .)]+[(pb9> Safer, J. D., & Coleman, E. (2016). Hormone therapy in transgender adults is safe with provider supervision. Journal of Clinical Endocrinology & Metabolism, 101(12), 4422–4426.https://pubmed.ncbi.nlm.nih.gov/28090436/ .)]
  
-[(pb10> Schagen, S. E., Cohen-Kettenis, P. T., Delemarre-van de Waal, H. A., & Hannema, S. E. (2016). Efficacy and safety of gonadotropin-releasing hormone agonist treatment to suppress puberty in gender dysphoric adolescents. The Journal of Adolescent Health, 59(3), 330–337. .)]+[(pb10> Schagen, S. E., Cohen-Kettenis, P. T., Delemarre-van de Waal, H. A., & Hannema, S. E. (2016). Efficacy and safety of gonadotropin-releasing hormone agonist treatment to suppress puberty in gender dysphoric adolescents. The Journal of Adolescent Health, 59(3), 330–337.https://pubmed.ncbi.nlm.nih.gov/27318023/ .)]
  
 [(pb11> Ibid. .)] [(pb11> Ibid. .)]
Line 345: Line 345:
 [(pb13> Ibid. .)] [(pb13> Ibid. .)]
  
-[(pb14> Arnoldussen, M., Steensma, T. D., Popma, A., van de Grift, T. C., Groote de Percin, S., & Cohen-Kettenis, P. T. (2022). Association between pre-treatment IQ and educational achievement after gender-affirming treatment including puberty suppression. Child Development, 93(3), 645–658. .)]+[(pb14> Arnoldussen, M., Steensma, T. D., Popma, A., van de Grift, T. C., Groote de Percin, S., & Cohen-Kettenis, P. T. (2022). Association between pre-treatment IQ and educational achievement after gender-affirming treatment including puberty suppression. Child Development, 93(3), 645–658.https://pubmed.ncbi.nlm.nih.gov/31473831/ .)]
  
 [(pb15> Transfemscience. (2022). Puberty blockers and cognitive development in transgender youth. Retrieved from https://transfemscience.org/ .)] [(pb15> Transfemscience. (2022). Puberty blockers and cognitive development in transgender youth. Retrieved from https://transfemscience.org/ .)]
Line 357: Line 357:
 [(pb19> U.S. Food and Drug Administration. (2022). FDA adds warnings about pseudotumor cerebri to labeling for GnRH agonists. FDA News. https://www.fda.gov/news-events/ .)] [(pb19> U.S. Food and Drug Administration. (2022). FDA adds warnings about pseudotumor cerebri to labeling for GnRH agonists. FDA News. https://www.fda.gov/news-events/ .)]
  
-[(pb20> Austin, S. B., Ziyadeh, N. J., Corliss, H. L., Rosario, M., Wypij, D., Haines, J., Jackson, B., Tandon, S. D., Miao, J., & Frazier, A. L. (2009). Sexual orientation disparities in pubertal timing in girls and boys. American Journal of Public Health, 99(8), 1496–1502. .)]+[(pb20> Austin, S. B., Ziyadeh, N. J., Corliss, H. L., Rosario, M., Wypij, D., Haines, J., Jackson, B., Tandon, S. D., Miao, J., & Frazier, A. L. (2009). Sexual orientation disparities in pubertal timing in girls and boys. American Journal of Public Health, 99(8), 1496–1502.https://pubmed.ncbi.nlm.nih.gov/19699419/ .)]
  
-[(pb21> Turban, J. L., King, D., Carswell, J. M., & Keuroghlian, A. S. (2022). Access to gender-affirming medical care associated with improved mental health for transgender adolescents and young adults. JAMA Network Open, 5(9), e2232980. .)]+[(pb21> Turban, J. L., King, D., Carswell, J. M., & Keuroghlian, A. S. (2022). Access to gender-affirming medical care associated with improved mental health for transgender adolescents and young adults. JAMA Network Open, 5(9), e2232980.https://pubmed.ncbi.nlm.nih.gov/31974216/ .)]
  
-[(pb22> Glynn, T. R., & van den Berg, J. J. (2017). A systematic review of interventions to reduce problematic substance use among transgender individuals. Transgender Health, 2(1), 159–177. .)]+[(pb22> Glynn, T. R., & van den Berg, J. J. (2017). A systematic review of interventions to reduce problematic substance use among transgender individuals. Transgender Health, 2(1), 159–177.https://pubmed.ncbi.nlm.nih.gov/28861547/ .)]
  
 [(pb23> Olson, K. R., Durwood, L., Baams, L., Cassinat, J. E., Deutsch, M. B., & Pfaff, C. W. (2022). Gender identity 5 years after social transition. Pediatrics, 150(2), e2021056082. https://publications.aap.org/pediatrics/article/150/2/e2021056082/186992/ .)] [(pb23> Olson, K. R., Durwood, L., Baams, L., Cassinat, J. E., Deutsch, M. B., & Pfaff, C. W. (2022). Gender identity 5 years after social transition. Pediatrics, 150(2), e2021056082. https://publications.aap.org/pediatrics/article/150/2/e2021056082/186992/ .)]
Line 367: Line 367:
 [(pb24> Coleman, E., Radix, A. E., Bouman, W. P., Brown, G. R., de Vries, A. L., Ehrensaft, D., Fraser, L., Garofalo, R., Karasic, D. H., Knudson, G. A., et al. (2012). Standards of care for the health of transsexual, transgender, and gender-nonconforming people, Version 7. International Journal of Transgenderism, 13(4), 165–232. .)] [(pb24> Coleman, E., Radix, A. E., Bouman, W. P., Brown, G. R., de Vries, A. L., Ehrensaft, D., Fraser, L., Garofalo, R., Karasic, D. H., Knudson, G. A., et al. (2012). Standards of care for the health of transsexual, transgender, and gender-nonconforming people, Version 7. International Journal of Transgenderism, 13(4), 165–232. .)]
  
-[(pb25> Austin, A., Craig, S. L., & D'Souza, S. A. (2018). An APA handbook of research in stigma, discrimination, and health. American Psychological Association. .)]+[(pb25> Austin, A., Craig, S. L., & D'Souza, S. A. (2018). An APA handbook of research in stigma, discrimination, and health. American Psychological Association.https://psycnet.apa.org/record/2017-53490-001 .)]
  
-[(pb26> Bariola, E., Lyons, A., Leonard, W., Pitts, M., Badcock, P., & Couch, M. (2015). Demographic and psychosocial factors associated with psychological distress and resilience in transgender individuals. The American Journal of Public Health, 105(10), 2108–2116. .)]+[(pb26> Bariola, E., Lyons, A., Leonard, W., Pitts, M., Badcock, P., & Couch, M. (2015). Demographic and psychosocial factors associated with psychological distress and resilience in transgender individuals. The American Journal of Public Health, 105(10), 2108–2116.https://pubmed.ncbi.nlm.nih.gov/26270284/ .)]
  
 [(pb27> Cass Review. (2024). Final Report. Available at: https://cass.independent-review.uk/home/publications/final-report/ .)] [(pb27> Cass Review. (2024). Final Report. Available at: https://cass.independent-review.uk/home/publications/final-report/ .)]
Line 391: Line 391:
 [(pb36> Ibid. .)] [(pb36> Ibid. .)]
  
-[(pb37> Turban, J. L., King, D., Carswell, J. M., & Keuroghlian, A. S. (2022). Access to gender-affirming medical care associated with improved mental health for transgender adolescents and young adults. JAMA Network Open, 5(9), e2232980. .)]+[(pb37> Turban, J. L., King, D., Carswell, J. M., & Keuroghlian, A. S. (2022). Access to gender-affirming medical care associated with improved mental health for transgender adolescents and young adults. JAMA Network Open, 5(9), e2232980.https://pubmed.ncbi.nlm.nih.gov/31974216/ .)]
  
 [(pb38> Hembree, W. C., Cohen-Kettenis, P. T., Gooren, L., Hannema, S. E., Meyer, W. J., Murad, M. H., Rosenthal, S. M., Safer, J. D., Tangpricha, V., & T'Sjoen, G. G. (2017). Endocrine treatment of gender-dysphoric/gender-incongruent persons: An Endocrine Society clinical practice guideline. The Journal of Clinical Endocrinology & Metabolism, 102(10), 3869–3903. https://academic.oup.com/jcem/article/102/10/3869/4157558 .)] [(pb38> Hembree, W. C., Cohen-Kettenis, P. T., Gooren, L., Hannema, S. E., Meyer, W. J., Murad, M. H., Rosenthal, S. M., Safer, J. D., Tangpricha, V., & T'Sjoen, G. G. (2017). Endocrine treatment of gender-dysphoric/gender-incongruent persons: An Endocrine Society clinical practice guideline. The Journal of Clinical Endocrinology & Metabolism, 102(10), 3869–3903. https://academic.oup.com/jcem/article/102/10/3869/4157558 .)]

Trace: • index • debunking-puberty-blockers • common-sources-misinfo

Print/export
QR Code
QR Code debunking-puberty-blockers (generated for current page)